E RACHMILEWITZ
Overview
Explore the profile of E RACHMILEWITZ including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
266
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rund D, RACHMILEWITZ E
Semin Hematol
. 2001 Oct;
38(4):343-9.
PMID: 11605169
At the molecular level, the underlying cause of thalassemia is any of a number of genetic lesions that reduce or abolish the production of the globin chains of hemoglobin. The...
2.
Dresner Pollack R, RACHMILEWITZ E, Blumenfeld A, Idelson M, Goldfarb A
Br J Haematol
. 2000 Dec;
111(3):902-7.
PMID: 11122154
Bone disease is an important cause of morbidity in older patients with beta-thalassaemia major and intermedia. We studied 27 women and 23 men with beta-thalassaemia major (37) and intermedia (13)...
3.
Rund D, RACHMILEWITZ E
Crit Rev Oncol Hematol
. 2000 Mar;
33(2):105-18.
PMID: 10737372
Thalassemia is the world's most common hereditary disease, and is a paradigm of monogenic genetic diseases. Because of increased population mobility, the disease is found today throughout the world, even...
4.
Asimakopoulos F, Shteper P, Krichevsky S, Fibach E, Polliack A, RACHMILEWITZ E, et al.
Blood
. 1999 Sep;
94(7):2452-60.
PMID: 10498618
Methylation of the proximal promoter of the ABL1 oncogene is a common epigenetic alteration associated with clinical progression of chronic myeloid leukemia (CML). In this study we queried whether both...
5.
Prognostic significance of c-ABL methylation in chronic myelogenous leukemia: still an open question
Asimakopoulos F, Shteper P, Fibach E, RACHMILEWITZ E, Ben-Neriah Y, Ben-Yehuda D
Blood
. 1999 Aug;
94(3):1141.
PMID: 10454801
No abstract available.
6.
Rund D, Fibach E, Goldfarb A, FRIEDBERG A, RACHMILEWITZ E
Acta Haematol
. 1998 Oct;
100(2):82-4.
PMID: 9792937
Hemin has a profound effect on erythroid cell maturation and promotes fetal hemoglobin synthesis in vitro. In beta-thalassemia, increasing fetal hemoglobin levels can ameliorate the anemia. We administered heme arginate,...
7.
Rund D, Oron-Karni V, Filon D, Goldfarb A, RACHMILEWITZ E, OPPENHEIM A
Am J Hematol
. 1997 Jan;
54(1):16-22.
PMID: 8980256
Molecular analysis was performed on 95 Israeli patients with thalassemia intermedia, representing 60 families of Arab (Moslem and Christian), Jewish, Druze, and Samaritan origin. There was a wide range of...
8.
Oron-Karni V, Filon D, Rund D, RACHMILEWITZ E, OPPENHEIM A
Am J Hematol
. 1996 Nov;
53(3):203-4.
PMID: 8895695
No abstract available.
9.
Chen S, Eldor A, Barshtein G, Zhang S, Goldfarb A, RACHMILEWITZ E, et al.
Am J Physiol
. 1996 Jun;
270(6 Pt 2):H1951-6.
PMID: 8764243
beta-Thalassemia major (TM), a congenital hemoglobinopathy, is associated with hemodynamic disorders and with structural red blood cell (RBC) anomalies that may indicate impairment of RBC rheological properties. To gain insight...
10.
Shpilberg O, Mark Z, Biniaminov M, Rosner E, Rosenthal E, Gipsh N, et al.
Leukemia
. 1995 Nov;
9(11):1974-8.
PMID: 7475293
No abstract available.